β-N-methylamino-L-alanine induces neurological deficits and shortened life span in drosophila

Toxins

Volumn 2, Issue 11, 2010, Pages 2663-2679

  Zhou, Xianchong ^a   Escala, Wilfredo ^b   Papapetropoulos, Spyridon ^a   Grace Zhai, R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Amyotrophic lateral sclerosis; Dementia; Neurodegeneration

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; ALANINE; GLUTAMIC ACID;

ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CLIMBING; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DIETARY INTAKE; DROSOPHILA; EMBRYO; FEMALE; FEMALE INFERTILITY; LEARNING; LIFESPAN; LOCOMOTION; MALE; MEMORY; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PHENOTYPE; PROGENY; SURVIVAL RATE;

AMINO ACIDS, DIAMINO; ANIMALS; BEHAVIOR, ANIMAL; BODY BURDEN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DROSOPHILA; EXCITATORY AMINO ACID AGONISTS; FEMALE; LEARNING; LOCOMOTION; LONGEVITY; MALE; MEMORY; NERVOUS SYSTEM; NEURODEGENERATIVE DISEASES;

EID: 79952125260     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins2112663     Document Type: Article

References (47)

1. Cox, P.A.; Sacks, O.W. Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam. Neurology 2002, 58, 956-959.
2. Kisby, G.E.; Ellison, M.; Spencer, P.S. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros. Neurology 1992, 42, 1336-1340.
3. Cox, P.A.; Banack, S.A.; Murch, S.J. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc. Natl. Acad. Sci. USA 2003, 100, 13380-13383.
4. Murch, S.J.; Cox, P.A.; Banack, S.A. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc. Natl. Acad. Sci. USA 2004, 101, 12228-12231.
5. Banack, S.A.; Johnson, H.E.; Cheng, R.; Cox, P.A. Production of the Neurotoxin BMAA by a Marine Cyanobacterium. Mar. Drugs 2007, 5, 180-196.
6. Metcalf, J.S.; Banack, S.A.; Lindsay, J.; Morrison, L.F.; Cox, P.A.; Codd, G.A. Co-occurrence of beta-N-methylamino-L-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990-2004. Environ. Microbiol. 2008, 10, 702-708.
7. Jonasson, S.; Eriksson, J.; Berntzon, L.; Spacil, Z.; Ilag, L.L.; Ronnevi, L.O.; Rasmussen, U.; Bergman, B. Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc. Natl. Acad. Sci. USA 2010, 107, 9252-9257.
8. Johnson, H.E.; King, S.R.; Banack, S.A.; Webster, C.; Callanaupa, W.J.; Cox, P.A. Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA. J. Ethnopharmacol. 2008, 118, 159-165.
9. Mash, D.C. Cyanobacterial toxins in neurodegeneration. Continuum ifelong Learn. Neurol. 2008, 14, 138-149.
10. Murch, S.J.; Cox, P.A.; Banack, S.A.; Steele, J.C.; Sacks, O.W. Occurrence of beta-methylamino- l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol. Scand. 2004, 110, 267-269.
11. Pablo, J.; Banack, S.A.; Cox, P.A.; Johnson, T.E.; Papapetropoulos, S.; Bradley, W.G.; Buck, A.; Mash, D.C. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol. Scand. 2009.
12. Papapetropoulos, S. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm. Neurochem. Int. 2007, 50, 998-1003.
13. Snyder, L.R.; Cruz-Aguado, R.; Sadilek, M.; Galasko, D.; Shaw, C.A.; Montine, T.J. Lack of cerebral bmaa in human cerebral cortex. Neurology 2009, 72, 1360-1361.
14. Lobner, D.; Piana, P.M.; Salous, A.K.; Peoples, R.W. Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol. Dis. 2007, 25, 360-366.
15. Rao, S.D.; Banack, S.A.; Cox, P.A.; Weiss, J.H. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp. Neurol. 2006, 201, 244-252.
16. Weiss, J.H.; Christine, C.W.; Choi, D.W. Bicarbonate dependence of glutamate receptor activation by beta-N-methylamino-L-alanine: Channel recording and study with related compounds. Neuron 1989, 3, 321-326.
17. Brownson, D.M.; Mabry, T.J.; Leslie, S.W. The cycad neurotoxic amino acid, beta-N- methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells. J. Ethnopharmacol. 2002, 82, 159-167.
18. Cruz-Aguado, R.; Winkler, D.; Shaw, C.A. Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice. Pharmacol. Biochem. Behav. 2006, 84, 294-299.
19. Karamyan, V.T.; Speth, R.C. Animal models of BMAA neurotoxicity: A critical review. Life Sci. 2008, 82, 233-246.
20. Zhou, X.; Escala, W.; Papapetropoulos, S.; Bradley, W.G.; Zhai, R.G. BMAA neurotoxicity in Drosophila. Amyotroph. Lateral. Scler. 2009, 10, 61-66.
21. Ganetzky, B.; Flanagan, J.R. On the relationship between senescence and age-related changes in two wild-type strains of Drosophila melanogaster. Exp. Gerontol. 1978, 13, 189-196.
22. Le Bourg, E.; Lints, F.A. Hypergravity and aging in Drosophila melanogaster. 4. Climbing activity. Gerontology 1992, 38, 59-64.
23. Le Bourg, E.; Buecher, C. Learned suppression of photopositive tendencies in Drosophila melanogaster. Anim. Learn. Behav. 2002, 30, 330-341.
24. Seugnet, L.; Suzuki, Y.; Stidd, R.; Shaw, P.J. Aversive phototaxic suppression: Evaluation of a short-term memory assay in Drosophila melanogaster. Genes Brain Behav. 2009, 8, 377-389.
25. Sang, T.K.; Jackson, G.R. Drosophila models of neurodegenerative disease. NeuroRx 2005, 2, 438-446.
26. Ratnaparkhi, A.; Lawless, G.M.; Schweizer, F.E.; Golshani, P.; Jackson, G.R. A Drosophila model of ALS: Human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS ONE 2008, 3, e2334.
27. Tsuda, H.; Han, S.M.; Yang, Y.; Tong, C.; Lin, Y.Q.; Mohan, K.; Haueter, C.; Zoghbi, A.; Harati, Y.; Kwan, J.; Miller, M.A.; Bellen, H.J. The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell 2008, 133, 963-977.
28. Watson, M.R.; Lagow, R.D.; Xu, K.; Zhang, B.; Bonini, N.M. A drosophila model for amyotrophic lateral sclerosis reveals motor neuron damage by human SOD1. J. Biol. Chem. 2008, 283, 24972-24981.
29. Benzer, S. From the gene to behavior. Jama 1971, 218, 1015-1022.
30. Benzer, S. Genetic dissection of behavior. Sci. Am. 1973, 229, 24-37.
31. Hotta, Y.; Benzer, S. Mapping of behavior in Drosophila mosaics. Symp. Soc. Dev. Biol. 1973, 31, 129-167.
32. Hirsch, J.; Boudreau, J.C. Studies in experimental behavior genetics. I. The heritability of phototaxis in a population of Drosophila melanogaster. J. Comp. Physiol. Psychol. 1958, 51, 647-651.
33. Hendel, T.; Michels, B.; Neuser, K.; Schipanski, A.; Kaun, K.; Sokolowski, M.B.; Marohn, F.; Michel, R.; Heisenberg, M.; Gerber, B. The carrot, not the stick: appetitive rather than aversive gustatory stimuli support associative olfactory learning in individually assayed Drosophila larvae. J. Comp. Physiol. A Neuroethol. Sens. Neural. Behav. Physiol. 2005, 191, 265-279.
34. Le Bourg, E. Effects of aging on learned suppression of photopositive tendencies in Drosophila melanogaster. Neurobiol. Aging 2004, 25, 1241-1252.
35. Meunier, N.; Marion-Poll, F.; Rospars, J.P.; Tanimura, T. Peripheral coding of bitter taste in Drosophila. J. Neurobiol. 2003, 56, 139-152.
36. Quinn, W.G.; Harris, W.A.; Benzer, S. Conditioned behavior in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 1974, 71, 708-712.
37. Bradley, W.G.; Mash, D.C. Beyond Guam: The cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph. Lateral. Scler. 2009, 10, 7-20.
38. Weiss, J.H.; Koh, J.Y.; Choi, D.W. Neurotoxicity of beta-N-methylamino-L-alanine (BMAA) and beta-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res. 1989, 497, 64-71.
39. Ross, S.M.; Seelig, M.; Spencer, P.S. Specific antagonism of excitotoxic action of 'uncommon' amino acids assayed in organotypic mouse cortical cultures. Brain Res. 1987, 425, 120-127.
40. Buenz, E.J.; Howe, C.L. Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo. Neurotoxicology 2007, 28, 702-704.
41. Cha, J.H.; Makowiec, R.L.; Penney, J.B.; Young, A.B. L-[3H]glutamate labels the metabotropic excitatory amino acid receptor in rodent brain. Neurosci. Lett. 1990, 113, 78-83.
42. Copani, A.; Canonico, P.L.; Catania, M.V.; Aronica, E.; Bruno, V.; Ratti, E.; van Amsterdam, F.T.; Gaviraghi, G.; Nicoletti, F. Interaction between beta-N-methylamino-L-alanine and excitatory amino acid receptors in brain slices and neuronal cultures. Brain Res. 1991, 558, 79-86.
43. Rakonczay, Z.; Matsuoka, Y.; Giacobini, E. Effects of L-beta-N-methylamino-L-alanine (L-BMAA) on the cortical cholinergic and glutamatergic systems of the rat. J. Neurosci. Res. 1991, 29, 121-126.
44. Liu, X.; Rush, T.; Zapata, J.; Lobner, D. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-). Exp. Neurol. 2009, 217, 429-433.
45. Lobner, D. Mechanisms of beta-N-methylamino-L-alanine induced neurotoxicity. Amyotroph. Lateral. Scler. 2009, 10, 56-60.
46. Nunn, P.B. Three phases of research on beta-N-methylamino-L-alanine (BMAA)-A neurotoxic amino acid. Amyotroph. Lateral. Scler. 2009, 10, 26-33.
47. Nunn, P.B.; Ponnusamy, M. Beta-N-methylaminoalanine (BMAA): Metabolism and metabolic effects in model systems and in neural and other tissues of the rat in vitro. Toxicon 2009, 54, 85-94.